![]() Growth was driven by our recent expansion to Arizona in addition to the continued progress of our Utah operations. Novamind CEO, Yaron Conforti, commented, “Once again, we’re pleased to report record-high revenue this quarter. It also closed a $5,000,000 private placement with an institutional investor. ![]() Novamind said it had total working capital of $3,928,642 to fund operations. Numinus Wellness will be buying Novamind in an all-share transaction. The company had a net loss of $2.4 million. Novamind reported total revenue of $3,227,352, an increase of 32% over the previous quarter. (CSE: NM)(OTCQB: NVMDF) reported its financial results for the fiscal third quarter ending March 31, 2022. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.Novamind Inc. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. ![]() There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. ![]() All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. This news release contains forward-looking statements. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit Contact Information Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. On January 5 th, 2021, Novamind began trading as a public company on the Canadian Securities Exchange under the ticker symbol “NM”. Novamind is using the proceeds to grow its network of mental health clinics and clinical research sites, organically and through acquisitions. The Company recently closed an oversubscribed private placement of CAN$10.0 million. Rifici joins the Board at a unique inflection point for Novamind. His expertise will guide our team as we scale our business and contribute to responsibly shaping psychedelic medicine.” Yaron Conforti, Chief Executive Officer and Director of Novamind commented: “Chuck is a tremendous asset to Novamind. A Chartered Professional Accountant, Rifici obtained his MBA from Queen’s University and holds a BASc in Computer Engineering from the University of Ottawa. From 2011 to 2016, Rifici served as Chief Financial Officer of the Liberal Party of Canada. He co-founded Canopy Growth Corporation (WEED), Auxly Cannabis Group Inc. Rifici brings a wealth of experience as a pioneering investor and operator in the cannabis sector. Be the first to know when breaking news are released.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |